About Bioline
Founded in 1992, Bioline, a brand of Meridian Bioscience, develops molecular biology reagents for nucleic acid research, molecular diagnostics and genomics. The company specialises in PCR, qPCR, reverse transcription, nucleic acid extraction and next-generation sequencing. Its products enable sensitive and reproducible DNA and RNA analysis. Bioline supports gene expression analysis, pathogen detection, genetic testing, synthetic biology, agricultural biotechnology and translational research. Its technologies simplify workflows from sample preparation to downstream analysis.
The portfolio includes PCR and qPCR master mixes, reverse transcriptases, DNA polymerases, extraction kits, cDNA synthesis reagents and NGS library preparation products. Key product families include MyTaq™, SensiFAST™ and Meridian Bioscience® molecular reagents. The range also includes enzymes and kits for research and diagnostic workflows. Bioline products are used in academic, clinical, industrial and public health laboratories. Applications include molecular assay development, gene expression studies, infectious disease research and genomic analysis.
Europa Biosite’s subsidiaries distribute for Bioline in Denmark, Estonia, Iceland, Latvia, Lithuania, Norway and Sweden.